Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BIO tax reform lobbying to include net operating loss provisions.

Executive Summary

BIO TAX REFORM LOBBYING WILL ADDRESS NOL CARRY-FORWARDS under Sec. 382 of the tax code, Biotechnology Industry Organization VP- Government Relations Chuck Ludlam said during a presentation on biotechnology tax issues in Washington, D.C. April 9. BIO is studying the change of ownership rule in Sec. 382, which requires a company that changes over 50% of its shareholders to amortize its net operating loss carry-forwards.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS027977

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel